IDXX
Idexx Laboratories, Inc.
Price performance
Sep 18, 2026About
Company activity
23 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/04 | IDXX | 8-K | IDEXX Laboratories Announces Second Quarter Financial Results | — | — | — |
| 05/15 | IDXX | 8-K | IDEXX Laboratories Declassifies Board and Updates Governance | — | — | — |
| 05/05 | IDXX | 8-K | IDEXX Laboratories Announces First Quarter 2026 Financial Results and Updated Guidance | — | — | — |
| 03/26 | IDXX | 8-K | IDEXX Laboratories Announces Departure of Executive Vice President | — | — | — |
| 02/13 | IDXX | 8-K | IDEXX Laboratories Announces Board Member Retirement | — | — | — |
| 02/02 | IDXX | 8-K | IDEXX Laboratories Announces Financial Results for 2025 | — | — | — |
| 01/13 | IDXX | 8-K | IDEXX Laboratories Announces CEO Transition with Michael Erickson Succeeding Jonathan Mazelsky | — | — | — |
| 11/13/25 | IDXX | 8-K | IDEXX Laboratories Amends Credit Agreement | — | — | — |
| 11/03/25 | IDXX | 8-K | IDEXX Laboratories Announces Third Quarter Financial Results | — | — | — |
| 10/07/25 | IDXX | 8-K | IDEXX Laboratories Elects Karen Peacock to Board of Directors | — | — | — |
| 08/04/25 | IDXX | 8-K | IDEXX Laboratories Reports Second Quarter Results | — | — | — |
| 07/10/25 | IDXX | 8-K | IDEXX Laboratories Elects New Independent Director | — | — | — |
| 05/09/25 | IDXX | 8-K | IDEXX Laboratories Updates Corporate Governance and Voting Rights | — | — | — |
| 05/01/25 | IDXX | 8-K | IDEXX Laboratories Reports First Quarter 2025 Results | — | — | — |
| 02/14/25 | IDXX | 8-K | Dr. Asha Collins Resigns from IDEXX Laboratories Board | — | — | — |
| 02/03/25 | IDXX | 8-K | IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results | — | — | — |
| 12/12/24 | IDXX | 8-K | IDEXX Laboratories Adopts New Deferred Compensation Plan | — | — | — |
| 12/09/24 | IDXX | 8-K | IDEXX Laboratories Announces Increase in Share Repurchase Program | — | — | — |
| 11/21/24 | IDXX | 8-K | IDEXX Laboratories Announces CFO Transition | — | — | — |
| 11/12/24 | IDXX | 8-K | Jonathan W. Ayers Resigns from IDEXX Laboratories Board | — | — | — |
| 11/06/24 | IDXX | 8-K | IDEXX Laboratories Extends Supply Agreements with Ortho | — | — | — |
| 10/31/24 | IDXX | 8-K | IDEXX Laboratories Corrects 2024 Profit Margin Outlook | — | — | — |
| 10/31/24 | IDXX | 8-K | IDEXX Laboratories Announces Third Quarter Financial Results | — | — | — |
IDXX filing record
Idexx Laboratories, Inc. (IDXX): 23 8-K filings summarized, the most recent on Aug 4, 2026.
What the 8-K filings said
- Aug 4, 2026 · low impact
IDEXX Laboratories, Inc. announced its financial results for the quarter ended June 30, 2026. The full details of the results are provided in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K.
IDEXX Laboratories Announces Second Quarter Financial Results - May 15, 2026 · medium impact
IDEXX Laboratories, Inc. has amended its Amended and Restated Certificate of Incorporation and By-Laws following approval by shareholders at the 2026 annual meeting. The key changes include the declassification of the Board, which will now be annually elected starting from the 2029 annual meeting, and a provision…
IDEXX Laboratories Declassifies Board and Updates Governance - May 5, 2026 · high impact
IDEXX Laboratories, Inc. reported first quarter 2026 financial results with revenue of $1,141 million, a 14% increase as reported and 11% organic. The company achieved EPS of $3.47, an increase of 17% as reported and 15% on a comparable basis. IDEXX raised its 2026 revenue guidance to $4,675 million - $4,760 million…
IDEXX Laboratories Announces First Quarter 2026 Financial Results and Updated Guidance - Mar 26, 2026 · high impact
IDEXX Laboratories, Inc. announced on March 24, 2026, that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will cease serving in her current role effective April 13, 2026. Dr. Hunt will continue to provide advisory services until July 13, 2026. The company will pay Dr. Hunt separation…
IDEXX Laboratories Announces Departure of Executive Vice President - Feb 13, 2026 · medium impact
IDEXX Laboratories, Inc. announced on February 13, 2026, that Ms. M. Anne Szostak will retire from the Board of Directors immediately following the Company's 2026 Annual Meeting on May 12, 2026. This decision is not due to any disagreement with the Company. The Board will reduce the size of Class III seats but…
IDEXX Laboratories Announces Board Member Retirement
SEC filings in the last five years
- 40 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 8-K/A